| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate |
1993-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6237cfe2a6bea8ffa814ded50c2703dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7ba75433299c16bcd26c2938a2824b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d5cb64e246e02d05499a97f7585d90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ad4ba478b51a9702c05454c6e52138 |
| publicationDate |
2000-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100263284-B1 |
| titleOfInvention |
Tablets with improved bioavailability containing dichloromethylenediphosphonic acid as active ingredient |
| abstract |
The present invention provides a tablet which exhibits an improved bioavailability having a clodronic acid or a physiologically acceptable salt thereof as an active substance and having a microcrystalline cellulose component as a pharmaceutical adjuvant, a pharmaceutical pack comprising such a tablet, an improved biomaterial It relates to a method of using dichlorokenylenediphosphonic acid as an active ingredient together with microcrystalline cellulose to prepare tablets with utilization and to methods of making such tablets. |
| priorityDate |
1993-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |